Discovery of a highly potent, selective, orally bioavailable inhibitor of KAT6A/B histone acetyltransferases with efficacy against KAT6A-high ER+ breast cancer
Titel:
Discovery of a highly potent, selective, orally bioavailable inhibitor of KAT6A/B histone acetyltransferases with efficacy against KAT6A-high ER+ breast cancer
Auteur:
Sharma, Shikhar Chung, Chi-Yeh Uryu, Sean Petrovic, Jelena Cao, Joan Rickard, Amanda Nady, Nataliya Greasley, Samantha Johnson, Eric Brodsky, Oleg Khan, Showkhin Wang, Hui Wang, Zhenxiong Zhang, Yong Tsaparikos, Konstantinos Chen, Lei Mazurek, Anthony Lapek, John Kung, Pei-Pei Sutton, Scott Richardson, Paul F. Greenwald, Eric C. Yamazaki, Shinji Jones, Rhys Maegley, Karen A. Bingham, Patrick Lam, Hieu Stupple, Alexandra E. Kamal, Aileen Chueh, Anderly Cuzzupe, Anthony Morrow, Benjamin J. Ren, Bin Carrasco-Pozo, Catalina Tan, Chin Wee Bhuva, Dharmesh D. Allan, Elizabeth Surgenor, Elliot Vaillant, François Pehlivanoglu, Havva Falk, Hendrik Whittle, James R. Newman, Janet Cursons, Joseph Doherty, Judy P. White, Karen L. MacPherson, Laura Devlin, Mark Dennis, Matthew L. Hattarki, Meghan K. De Silva, Melanie Camerino, Michelle A. Butler, Miriam S. Dolezal, Olan Pilling, Patricia Foitzik, Richard Stupple, Paul A. Lagiakos, H. Rachel Walker, Scott R. Hediyeh-Zadeh, Soroor Nuttall, Stewart Spall, Sukhdeep K. Charman, Susan A. Connor, Theresa Peat, Thomas S. Avery, Vicky M. Bozikis, Ylva E. Yang, Yuqing Zhang, Ming Monahan, Brendon J. Voss, Anne K. Thomas, Tim Street, Ian P. Dawson, Sarah-Jane Dawson, Mark A. Lindeman, Geoffrey J. Davis, Melissa J. Visvader, Jane E. Paul, Thomas A.